Regional Medicare carrier now covers non-surgical stress urinary incontinence treatment
Novasys Medical, Inc. (Newark, CA) recently announced that Noridian Administrative Services, LLC, a regional Medicare carrier, is now covering the non-surgical Renessa treatment for women with stress urinary incontinence.
Novasys Medical, Inc. (Newark, CA) recently announced that Noridian Administrative Services, LLC, a regional Medicare carrier, is now covering the non-surgical Renessa treatment for women with stress urinary incontinence.
According to Noridian’s web site, the insurer “will now cover CPT 0193T, transurethral, radiofrequency micro-remodeling of the female bladder neck and proximal urethra for stress urinary incontinence. This includes the Renessa transurethral collagen radiofrequency denaturation procedure.”
The web site also states, “Coverage will be allowed when the procedure is performed consistent with FDA labeling and in accordance with the indications supported by peer-reviewed literature.” The policy specifies that coverage only applies to cases of moderate to severe female SUI.
The Renessa System includes a small probe that a physician passes through the urethra. The probe heats multiple small treatment sites in the submucosa of the bladder neck and upper urethra, denaturing the patient’s own collagen in the tissue, thereby reducing or eliminating leaks.
AUA, SUFU publish 2024 guideline for idiopathic overactive bladder
April 25th 2024“This brand new guideline offers options for all patients with OAB with a focus on shared decision-making between patients with OAB and clinicians, as well as a personalized, tailored approach to care,” said Cameron and Smith.
Enzalutamide granted approval in EU for nmHSPC
April 24th 2024The approval is supported by data from the phase 3 EMBARK trial, which demonstrated that enzalutamide with or without leuprolide prolonged metastasis-free survival compared with leuprolide alone in patients with high-risk biochemically recurrent nmHSPC.
